Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

Details for Australian Patent Application No. 2008329876 (hide)

Owner Alcon Research, Ltd.

Inventors Dixit, Suresh C.; Singh, Onkar N.; Wall, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2008329876

PCT Pub. Number WO2009/070530

Priority 60/990,452 27.11.07 US

Filing date 24 November 2008

Wipo publication date 4 June 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/070530 Priority application(s): WO2009/070530

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008329884-Flexible magnetic sheet systems

2008329872-Fluid handling device with ultrasound sensor and methods and systems using same